La Jolla Pharmaceutical
(NASDAQ) LJPC
La Jolla Pharmaceutical Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$46.49M
Net Income (TTM)
$1.52M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
LJPC News
LJPC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout La Jolla Pharmaceutical
Industry
Biotechnology
Sector
Health CareEmployees
66
CEO
Larry G. Edwards
Headquarters
San Diego, CA 02451, US
LJPC Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
29%
Net Income Margin
26%
Return on Equity
-25%
Return on Capital
26%
Return on Assets
19%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$62.23M
Operating Income
$21.83M
EBITDA
$32.05M
Operating Cash Flow
$28.24M
Capital Expenditure
$9.00K
Free Cash Flow
$28.23M
Cash & ST Invst.
$46.67M
Total Debt
$2.64M
La Jolla Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$10.54M
-34.3%
Gross Profit
$8.85M
-36.3%
Gross Margin
83.96%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
61
N/A
Net Income
$2.46M
-34.2%
EBITDA
$5.25M
-23.8%
Quarterly Fundamentals
Net Cash
$48.43M
+12.2%
Accounts Receivable
$5.93M
-31.0%
Inventory
$8.30M
+51.4%
Long Term Debt
$75.00K
-97.1%
Short Term Debt
$157.00K
-6.5%
Return on Assets
19.42%
N/A
Return on Invested Capital
26.12%
N/A
Free Cash Flow
$6.68M
-6.4%
Operating Cash Flow
$6.68M
-6.4%